Related by context. Frequent words. (Click for all words.) 64 Phase 2a trial 63 Phase Ib 63 dose escalation 62 Phase 2b study 62 Phase IIa trial 62 eltrombopag 61 tolerated dose MTD 61 phase IIb 61 Phase 2b trial 61 phase IIa 61 PROMACTA 61 Phase 1b 61 elagolix 60 HGS ETR1 59 PXD# 59 limiting toxicity 59 Phase IIb clinical 59 Phase III 59 Phase 2a clinical 58 vicriviroc 58 INCB# [002] 58 AP# [003] 58 mipomersen 57 Phase IIb 57 Phase 2b 57 vandetanib 57 phase 2a 57 Phase IIa 57 DSMB 57 CoFactor 57 AZD# 57 ZYBRESTAT 57 dose limiting toxicities 57 ISIS # 57 IMGN# 57 CA4P 57 Phase 1b clinical 56 NGX# 56 LymphoStat B 56 ISENTRESS 56 sapacitabine 56 Phase III clinical 56 Phase 2a 56 Phase III Trial 56 multiple ascending dose 56 Pharmacokinetic 56 FOLOTYN 55 sunitinib 55 BAY #-# 55 Phase IIa clinical 55 Phase 2b clinical 55 Phase IIb trial 55 Phase II 55 PRX # 55 dose escalation trial 55 PhosLo 55 Zerenex 55 MGCD# [001] 55 TORISEL 55 PEG Interferon lambda 55 confirmatory Phase 3 55 pharmacokinetic profile 55 unblinded 55 denufosol 54 darusentan 54 valopicitabine 54 daclizumab 54 motavizumab 54 FTY# 54 imetelstat 54 Azixa 54 OXi# 54 MDV# 54 Welchol 54 pharmacodynamics 54 antitumor activity 54 PF # [001] 54 SILENOR TM 54 crofelemer 54 Phase III trials 53 RG# [001] 53 Ventavis 53 GVAX 53 XL# [003] 53 laquinimod 53 Board DSMB 53 pivotal Phase III 53 abatacept 53 non inferiority 53 PS# [001] 53 methylnaltrexone 53 Torisel 53 tolerability 53 JANUVIA 53 bosentan 53 dose escalation study 53 relapsed multiple myeloma 53 TroVax 53 HspE7 53 Phase III pivotal 53 cetrorelix